National Institute of Mental Health: Notice of Meeting, 941-942 [2016-196]

Download as PDF asabaliauskas on DSK5VPTVN1PROD with NOTICES Federal Register / Vol. 81, No. 5 / Friday, January 8, 2016 / Notices Received comments will be placed in the docket and, except for those submitted as ‘‘Confidential Submissions,’’ publicly viewable at https://www.regulations.gov or at the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. • Confidential Submissions—To submit a comment with confidential information that you do not wish to be made publicly available, submit your comments only as a written/paper submission. You should submit two copies total. One copy will include the information you claim to be confidential with a heading or cover note that states ‘‘THIS DOCUMENT CONTAINS CONFIDENTIAL INFORMATION.’’ The Agency will review this copy, including the claimed confidential information, in its consideration of comments. The second copy, which will have the claimed confidential information redacted/blacked out, will be available for public viewing and posted on https:// www.regulations.gov. Submit both copies to the Division of Dockets Management. If you do not wish your name and contact information to be made publicly available, you can provide this information on the cover sheet and not in the body of your comments and you must identify this information as ‘‘confidential.’’ Any information marked as ‘‘confidential’’ will not be disclosed except in accordance with 21 CFR 10.20 and other applicable disclosure law. For more information about FDA’s posting of comments to public dockets, see 80 FR 56469, September 18, 2015, or access the information at: https://www.fda.gov/ regulatoryinformation/dockets/ default.htm. Docket: For access to the docket to read background documents or the electronic and written/paper comments received, go to https:// www.regulations.gov and insert the docket number, found in brackets in the heading of this document, into the ‘‘Search’’ box and follow the prompts and/or go to the Division of Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Submit written requests for single copies of the draft guidance to the Division of Drug Information, Center for Drug Evaluation and Research, Food and Drug Administration, 10001 New Hampshire Ave., Hillandale Building, 4th Floor, Silver Spring, MD 20993– 0002. Send one self-addressed adhesive label to assist that office in processing your requests. See the SUPPLEMENTARY INFORMATION section for electronic access to the draft guidance document. VerDate Sep<11>2014 20:40 Jan 07, 2016 Jkt 238001 FOR FURTHER INFORMATION CONTACT: Kristen Hardin, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 22, Rm. 5443, Silver Spring, MD 20993–0002, 240– 402–4246. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of November 23, 2015 (80 FR 72975), FDA published a notice of availability with a 60-day comment period for the draft guidance for industry entitled ‘‘Over-the-Counter Sunscreens: Safety and Effectiveness Data.’’ Publication of that draft guidance was mandated by the Sunscreen Innovation Act (SIA), which also requires FDA to publish the final guidance no later than November 26, 2016. The Agency has received a request for a 30-day extension of the comment period to provide more time for regulated industry to prepare a detailed and meaningful response to the draft guidance. FDA has considered the request and is extending the comment period for 30 days, until February 22, 2016. The Agency believes that a 30-day extension will allow adequate time for interested persons to submit comments without compromising timely publication of the final guidance as mandated by the SIA. II. Electronic Access Persons with access to the Internet may obtain the draft guidance at either https://www.fda.gov/Drugs/ GuidanceCompliance RegulatoryInformation/Guidances/ default.htm or https:// www.regulations.gov. Dated: January 4, 2016. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2016–128 Filed 1–7–16; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health: Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Mental Health Council. The meeting will be open to the public as indicated below, with attendance limited to space available. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 941 Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Mental Health Council. Date: February 4, 2016. Closed: 8:00 a.m. to 9:00 a.m. Agenda: To review and evaluate the NIMH Division of Intramural Research Programs. Place: National Institutes of Health, Neuroscience Center, Conference Rooms C/ D/E, 6001 Executive Boulevard, Rockville, MD 20852. Open: 9:15 a.m. to 1:00 p.m. Agenda: Presentation of the NIMH Director’s Report and discussion of NIMH program and policy issues. Place: National Institutes of Health, Neuroscience Center, Conference Rooms C/ D/E, 6001 Executive Boulevard, Rockville, MD 20852. Closed: 2:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, Conference Rooms C/ D/E, 6001 Executive Boulevard, Rockville, MD 20852. Contact Person: Jean G. Noronha, Ph.D., Director, Division of Extramural Activities National Institute of Mental Health, NIH Neuroscience Center, 6001 Executive Blvd., Room 6147, MSC 9609, Bethesda, MD 20892– 9609, 301–443–3367, jnoronha@mail.nih.gov. Any member of the public interested in presenting oral comments to the committee may notify the Contact Person listed on this notice at least 10 days in advance of the meeting. Interested individuals and representatives of organizations may submit a letter of intent, a brief description of the organization represented, and a short description of the oral presentation. Only one representative of an organization may be allowed to present oral comments and if accepted by the committee, presentations may be limited to five minutes. Both printed and electronic copies are requested for the record. In addition, any interested person may file written comments with the committee E:\FR\FM\08JAN1.SGM 08JAN1 942 Federal Register / Vol. 81, No. 5 / Friday, January 8, 2016 / Notices by forwarding their statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: www.nimh.nih.gov/about/advisoryboards-and-groups/namhc/index.shtml., where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: January 4, 2016. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–196 Filed 1–7–16; 8:45 am] BILLING CODE 4140–01–P Dated: January 5, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health asabaliauskas on DSK5VPTVN1PROD with NOTICES Center for Scientific Review: Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 13– 374: Modeling Social Behavior. Date: January 25, 2016. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. VerDate Sep<11>2014 20:40 Jan 07, 2016 Jkt 238001 Place: Embassy Suites at DC Convention Center, 900 10th Street NW., Washington, DC 20001. Contact Person: Gabriel B Fosu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3108, MSC 7808, Bethesda, MD 20892, (301) 435– 3562, fosug@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Systems Science and Health in the Behavioral and Social Sciences. Date: January 25, 2016. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at DC Convention Center, 900 10th Street NW., Washington, DC 20001. Contact Person: Gabriel B Fosu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3108, MSC 7808, Bethesda, MD 20892, (301) 435– 3562, fosug@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) [FR Doc. 2016–195 Filed 1–7–16; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism: Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which Frm 00041 Fmt 4703 Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; NIAAA PAR15–154 and Fellowship Applications. Date: January 26, 2016. Time: 1:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: NIAAA, NIH, 5635 Fishers Lane, CR 2098, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Ranga Srinivas, Ph.D., Chief, Scientific Review Officer, Extramural Project Review Branch, National Institutes of Health, 5365 Fishers Lane, Room 2085, Rockville, MD 20852, (301) 451–2067, srinivar@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.271, Alcohol Research Career Development Awards for Scientists and Clinicians; 93.272, Alcohol National Research Service Awards for Research Training; 93.273, Alcohol Research Programs; 93.891, Alcohol Research Center Grants; 93.701, ARRA Related Biomedical Research and Research Support Awards., National Institutes of Health, HHS) Dated: January 5, 2016. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–194 Filed 1–7–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health BILLING CODE 4140–01–P PO 00000 would constitute a clearly unwarranted invasion of personal privacy. Sfmt 4703 Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group Macromolecular Structure and Function C Study Section. Date: February 4–5, 2016. E:\FR\FM\08JAN1.SGM 08JAN1

Agencies

[Federal Register Volume 81, Number 5 (Friday, January 8, 2016)]
[Notices]
[Pages 941-942]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-196]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health: Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
National Advisory Mental Health Council.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Advisory Mental Health Council.
    Date: February 4, 2016.
    Closed: 8:00 a.m. to 9:00 a.m.
    Agenda: To review and evaluate the NIMH Division of Intramural 
Research Programs.
    Place: National Institutes of Health, Neuroscience Center, 
Conference Rooms C/D/E, 6001 Executive Boulevard, Rockville, MD 
20852.

    Open: 9:15 a.m. to 1:00 p.m.
    Agenda: Presentation of the NIMH Director's Report and 
discussion of NIMH program and policy issues.
    Place: National Institutes of Health, Neuroscience Center, 
Conference Rooms C/D/E, 6001 Executive Boulevard, Rockville, MD 
20852.
    Closed: 2:00 p.m. to 5:00 p.m.

    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 
Conference Rooms C/D/E, 6001 Executive Boulevard, Rockville, MD 
20852.
    Contact Person: Jean G. Noronha, Ph.D., Director, Division of 
Extramural Activities National Institute of Mental Health, NIH 
Neuroscience Center, 6001 Executive Blvd., Room 6147, MSC 9609, 
Bethesda, MD 20892-9609, 301-443-3367, jnoronha@mail.nih.gov.

    Any member of the public interested in presenting oral comments to 
the committee may notify the Contact Person listed on this notice at 
least 10 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. Only one representative of an organization may 
be allowed to present oral comments and if accepted by the committee, 
presentations may be limited to five minutes. Both printed and 
electronic copies are requested for the record. In addition, any 
interested person may file written comments with the committee

[[Page 942]]

by forwarding their statement to the Contact Person listed on this 
notice. The statement should include the name, address, telephone 
number and when applicable, the business or professional affiliation of 
the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one form 
of identification (for example, a government-issued photo ID, driver's 
license, or passport) and to state the purpose of their visit.
    Information is also available on the Institute's/Center's home 
page: www.nimh.nih.gov/about/advisory-boards-and-groups/namhc/index.shtml., where an agenda and any additional information for the 
meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program No. 93.242, Mental 
Health Research Grants, National Institutes of Health, HHS)

    Dated: January 4, 2016.
Carolyn A. Baum,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-196 Filed 1-7-16; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.